Study seeking to isolate antibodies against rabies virus

April 30, 2018, Vanderbilt University

Few people die from rabid animal bites in the United States thanks to the near-universal availability of human rabies immune globulin and rabies vaccine, which are given as separate shots as soon as possible after exposure to the rabies virus.

That isn't the case in resource-poor countries. Around the world, an estimated 60,000 people die from rabies every year because they can't afford or don't have prompt access to the necessary combined treatment.

Immune globulin (the antibody part of the blood) is obtained from people who have previously been vaccinated against rabies. Rabies-vaccinated donors are few and far between in many countries, however, and as a result immune globulin is often in short supply.

To meet the challenge, James Crowe Jr., MD, and his colleagues in the Vanderbilt Vaccine Center have begun an effort to isolate against the . Monoclonal antibodies can be mass-produced and manufactured as biological drugs.

If the research is successful, anti-rabies could be developed as the standard treatment for animal bites throughout the world, Crowe said. That would solve the chronic shortage of human and save many lives.

Because identifying the initial antibodies as candidates for development is a small project, Crowe's lab is pursuing a "crowdfunding" approach to raising the $18,000 it needs to complete the research by the end of 2018 rather than apply for government or foundation support.

"Crowdfunding allows people who are interested in this work to participate and support it directly," said Crowe, the Ann Scott Carell Professor in the Departments of Pediatrics and Pathology, Microbiology and Immunology in the Vanderbilt University School of Medicine.

"The funding mechanism allows us to update the donors directly in real-time on our progress," Crowe added. Donors also can submit questions or comments for the researchers.

Explore further: Clinical trial for rabies monoclonal antibody

More information: For more information, see experiment.com/projects/potent … t-for-rabies-disease

Related Stories

Clinical trial for rabies monoclonal antibody

August 7, 2012
A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute ...

Researchers identify potential antibody treatment for H7 avian flu

March 9, 2016
Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.

6-year-old Florida boy dies of rabies contracted from a bat

January 15, 2018
A 6-year-old Florida boy has died from rabies he contracted after being scratched by an infected bat.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.